PHARMACEUTICAL PREPARATIONS, NAMELY, ANTI-INTERLEUKIN-6 (IL-6) RECEPTOR MONOCLONAL ANTIBODY FOR THE TREATMENT OF DISEASE CAUSED BY IL-6 PRODUCTION